Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation - Quiz - MDSpire

Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation

  • By

  • Gioele Capoferri

  • Carla Simone Walti

  • Pascal Urwyler

  • Silvio Ragozzino

  • Jakob R. Passweg

  • Jörg Halter

  • Manuel Battegay

  • Veronika Baettig

  • Maja Weisser

  • Brice Arnold

  • Benedict Morin

  • Yukino Guetlin

  • Diana Albertos Torres

  • Güliz Tuba Barut

  • Volker Thiel

  • Adrian Egli

  • Beatrice Drexler

  • Nina Khanna

  • February 16, 2023

  • 0 min

Share

Original Source(s)

Dynamics of antibody titers to SARS-CoV-2 and clinical outcomes after sotrovimab pre-exposure prophylaxis early after allogeneic hematopoietic stem cell transplantation

  • by Gioele Capoferri, Carla Simone Walti, Pascal Urwyler, Silvio Ragozzino, Jakob R. Passweg, Jörg Halter, Manuel Battegay, Veronika Baettig, Maja Weisser, Brice Arnold, Benedict Morin, Yukino Guetlin, Diana Albertos Torres, Güliz Tuba Barut, Volker Thiel, Adrian Egli, Beatrice Drexler, Nina Khanna

  • February 16, 2023

Related Content

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis

Viral infections and risk, in Wine and Medicine

Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes